2006•Journal of Medical ForumRequires access

Significance and Expression of Bax in Non-small-cell Lung Cancer

Xing Lihua

Open publisher page 0 citations

Abstract

Objective To investigate the relationship between the expression of Bax and the clinical pathology characteristic in non-small-cell lung cancer(NSCLC). Methods The expression of Bax was detected in 80 NSCLC samples and 40 lung benign lesion tissues as control by immunohistochemistry(S-P). Results ①The expression level of Bax (63.8%) was found to be significantly higherl in NSCLC tissues than in benign lesion tissues(22.5%) (P0.01);②The Bax expression level of Bax was closely related to P-TNM stage and lymphnode involvement in lung cancer patients(P0.05). Conclusion The increase of Bax expression is may be related to the pathogenesis and development of lung cancer.

About this research paper

What this paper is about

Objective To investigate the relationship between the expression of Bax and the clinical pathology characteristic in non-small-cell lung cancer(NSCLC). Methods The expression of Bax was detected in 80 NSCLC samples and 40 lung benign lesion tissues as control by immunohistochemistry(S-P). Results ①The expression level of Bax (63.8%) was found to be significantly higherl in NSCLC tissues than in benign lesion tissues(22.5%) (P0.01);②The Bax expression level of Bax was closely related to P-TNM stage and lymphnode involvement in lung cancer patients(P0.05). Conclusion The increase of Bax expression is may be related to the pathogenesis and development of lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the relationship between the expression of Bax and the clinical pathology characteristic in non-small-cell lung cancer(NSCLC). Methods The expression of Bax was detected in 80 NSCLC samples and 40 lung benign lesion tissues as control by immunohistochemistry(S-P). Results ①The expression level of Bax (63.8%) was found to be significantly higherl in NSCLC tissues than in benign lesion tissues(22.5%) (P0.01);②The Bax expression level of Bax was closely related to P-TNM stage and lymphnode involvement in lung cancer patients(P0.05). Conclusion The increase of Bax expression is may be related to the pathogenesis and development of lung cancer.

Key concepts: Lung cancer, Immunohistochemistry, Pathology, Lung, Stage (stratigraphy), Lesion, Pathogenesis, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Significance and Expression of Bax in Non-small-cell Lung Cancer — Research Paper | ScholarLens